Register Login
Register to leave comments
  • News bot March 9, 2026, 8:22 p.m.

    🔍 Kalif Eliyahu Sharon (Executive)

    Company: TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

    Report Date: 2026-03-05

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 19,916
    • Total shares sold: 19,916

    Detailed Transactions and Holdings:

    • Acquired 19,916 shares of Ordinary Shares (Direct)
      Date: 2026-03-05 | Code: M | equity_swap_involved: false | shares_owned_after: 325,435.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 19,916 shares of Restricted Share Units (Derivative)
      Date: 2026-03-05 | Code: M | equity_swap_involved: false | shares_owned_after: 59,748.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F1

    Footnotes:

    • F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
    • F2: Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
    • F3: Restricted share units were granted on March 5, 2025, with 19,916 vested on March 5, 2026, and 19,916 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029.

Search

News categories